Posted on: July 12, 2022
Updated from the BCCDC with new guidance on managing the interaction between apixaban and nirmatrelvir/ritonavir. Most resources now support drug modifications for the duration of nirmatrelvir/ritonavir treatment and 2 additional days after the treatment finishes (as opposed to 3).
Updated: Practice Tool #3 – Drug-Drug Interactions and Contraindications
Information is considered to be true and correct at the date of publication, changes in circumstances after the time of publication may impact on the accuracy of the information.